Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles
- DOI
- 10.1007/s40261-026-01576-6
- Published
- 2026-07-06
- Container
- Clinical Drug Investigation
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40261-026-01576-6,
title = {Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles},
author = {Claudia Carmassi and Christoph U. Correll and Javier de Diego-Adeliño and Antonio Vian-Lains and Ciro Oliveira and Alex Schneider-Pérez and Vikas Mohan Sharma},
year = {2026},
journal = {Clinical Drug Investigation},
doi = {10.1007/s40261-026-01576-6},
url = {https://doi.org/10.1007/s40261-026-01576-6}
}RIS
TY - JOUR TI - Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles AU - Claudia Carmassi AU - Christoph U. Correll AU - Javier de Diego-Adeliño AU - Antonio Vian-Lains AU - Ciro Oliveira AU - Alex Schneider-Pérez AU - Vikas Mohan Sharma PY - 2026 JO - Clinical Drug Investigation DO - 10.1007/s40261-026-01576-6 UR - https://doi.org/10.1007/s40261-026-01576-6 ER -
APA
Carmassi, C., Correll, C. U., Diego-Adeliño, J. D., Vian-Lains, A., Oliveira, C., Schneider-Pérez, A., & Sharma, V. M. (2026). Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles. Clinical Drug Investigation. https://doi.org/10.1007/s40261-026-01576-6
Source records
- crossref · retrieved 2026-09-26T07:51:33.882Z